AU2013205006B9 - Gene Therapy Vectors and Cytosine Deaminases - Google Patents

Gene Therapy Vectors and Cytosine Deaminases

Info

Publication number
AU2013205006B9
AU2013205006B9 AU2013205006A AU2013205006A AU2013205006B9 AU 2013205006 B9 AU2013205006 B9 AU 2013205006B9 AU 2013205006 A AU2013205006 A AU 2013205006A AU 2013205006 A AU2013205006 A AU 2013205006A AU 2013205006 B9 AU2013205006 B9 AU 2013205006B9
Authority
AU
Australia
Prior art keywords
gene therapy
therapy vectors
cytosine deaminases
deaminases
cytosine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU2013205006A
Other versions
AU2013205006B2 (en
AU2013205006A1 (en
Inventor
Harry E. Gruber
Douglas Jolly
Christopher R. Logg
Omar Perez
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Forte Biosciences Inc
Original Assignee
Tocagen Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AU2009303690A external-priority patent/AU2009303690B2/en
Application filed by Tocagen Inc filed Critical Tocagen Inc
Priority to AU2013205006A priority Critical patent/AU2013205006B9/en
Publication of AU2013205006A1 publication Critical patent/AU2013205006A1/en
Publication of AU2013205006B2 publication Critical patent/AU2013205006B2/en
Application granted granted Critical
Publication of AU2013205006B9 publication Critical patent/AU2013205006B9/en
Ceased legal-status Critical Current
Anticipated expiration legal-status Critical

Links

AU2013205006A 2008-09-26 2013-04-13 Gene Therapy Vectors and Cytosine Deaminases Ceased AU2013205006B9 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2013205006A AU2013205006B9 (en) 2008-09-26 2013-04-13 Gene Therapy Vectors and Cytosine Deaminases

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US61/100,666 2008-09-26
US61/120,618 2008-12-08
US61/186,823 2009-06-13
AU2009303690A AU2009303690B2 (en) 2008-09-26 2009-09-26 Gene therapy vectors and cytosine deaminases
AU2013205006A AU2013205006B9 (en) 2008-09-26 2013-04-13 Gene Therapy Vectors and Cytosine Deaminases

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
AU2009303690A Division AU2009303690B2 (en) 2008-09-26 2009-09-26 Gene therapy vectors and cytosine deaminases

Publications (3)

Publication Number Publication Date
AU2013205006A1 AU2013205006A1 (en) 2013-05-16
AU2013205006B2 AU2013205006B2 (en) 2016-02-18
AU2013205006B9 true AU2013205006B9 (en) 2016-03-17

Family

ID=

Similar Documents

Publication Publication Date Title
IL264214A (en) Gene therapy vectors and cytosine deaminases
ZA201102287B (en) Porphobilinogen deaminase gene therapy
HK1205530A1 (en) Gene expression and pain
EP2037892A4 (en) Modified factor viii and factor ix genes and vectors for gene therapy
ZA201104532B (en) Axmi-150 delta-endotoxin gene and methods for its use
EP2356134A4 (en) Optically-based stimulation of target cells and modifications thereto
EP2518147A4 (en) Diacylglycerole acyltranferase gene, and use thereof
EP2209518A4 (en) Onset-mitigating high-frequency nerve block
ZA201104784B (en) Pesticidal genes from brevibacillus and methods for their use
GB0602992D0 (en) Methods, genes and proteins
ZA201006797B (en) Expression-linked gene discovery
ZA201005866B (en) Closterovirus vectors and methods
EP2212435A4 (en) Fused gene(s)
HK1141831A1 (en) Vector for gene therapy
SG10201403038SA (en) Identification of biologically and clinically essential genes and gene pairs, and methods employing the identified genes and gene pairs
EP2192402A4 (en) Enzyme electrode
EP2117588A4 (en) Viral vectors and methods of use
EP2227485A4 (en) Resistance gene and uses thereof
GB0718542D0 (en) Targeted modulation of gene expression
GB0406728D0 (en) Gene therapy
EP2185706A4 (en) Improved gene silencing methods
EP2287299A4 (en) Gene that imparts oxygen resistance and application thereof
EP2217721A4 (en) Osteoarthritis gene therapy
IL210411A0 (en) Rna antagonists targeting hsp27 and uses thereof
WO2011040954A9 (en) Tp53 gene expression and uses thereof